Viscofan Total Liabilities
Viscofan total liabilities. Based on the latest financial reports, Viscofan (VIS) has total liabilities worth €606.98 Million EUR (≈ $709.63 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Viscofan liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Viscofan (2000–2025)
Total liabilities of Viscofan from 2000 to 2025. This chart illustrates how Viscofan's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Viscofan's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Viscofan Competitors by Total Liabilities
The table below lists competitors of Viscofan ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Russel Metals Inc.
TO:RUS
|
Canada | CA$1.10 Billion |
|
K+S Aktiengesellschaft
F:SDF1
|
Germany | €2.81 Billion |
|
Guangzhou Haozhi Industrial Co Ltd
SHE:300503
|
China | CN¥1.71 Billion |
|
Aerospace CH UAV Co Ltd
SHE:002389
|
China | CN¥2.14 Billion |
|
Liberty Live Holdings, Inc. Series A Liberty Live Group Common Stock
NASDAQ:LLYVA
|
USA | $2.62 Billion |
|
Okeanis Eco Tankers Corp
OL:OET
|
Norway | Nkr654.82 Million |
|
Shihlin Electric & Engineering Corp
TW:1503
|
Taiwan | NT$20.40 Billion |
|
Taseko Mines Ltd
TO:TKO
|
Canada | CA$1.82 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Viscofan's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Viscofan's balance sheet.
Liquidity & Leverage Metrics
Viscofan Total Liabilities Ratios Explained
Viscofan total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Viscofan's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Viscofan (2000–2025)
The table below shows the annual total liabilities of Viscofan from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €504.10 Million ≈ $589.34 Million |
+8.66% |
| 2024-12-31 | €463.94 Million ≈ $542.39 Million |
+3.16% |
| 2023-12-31 | €449.74 Million ≈ $525.79 Million |
+2.09% |
| 2022-12-31 | €440.52 Million ≈ $515.02 Million |
+27.31% |
| 2021-12-31 | €346.02 Million ≈ $404.53 Million |
+13.75% |
| 2020-12-31 | €304.19 Million ≈ $355.63 Million |
+1.18% |
| 2019-12-31 | €300.64 Million ≈ $351.48 Million |
+8.88% |
| 2018-12-31 | €276.12 Million ≈ $322.81 Million |
+18.44% |
| 2017-12-31 | €233.12 Million ≈ $272.55 Million |
+4.58% |
| 2016-12-31 | €222.91 Million ≈ $260.61 Million |
+12.17% |
| 2015-12-31 | €198.72 Million ≈ $232.33 Million |
-33.99% |
| 2014-12-31 | €301.03 Million ≈ $351.94 Million |
+11.88% |
| 2013-12-31 | €269.06 Million ≈ $314.56 Million |
-3.56% |
| 2012-12-31 | €279.00 Million ≈ $326.18 Million |
+12.56% |
| 2011-12-31 | €247.86 Million ≈ $289.77 Million |
-12.36% |
| 2010-12-31 | €282.80 Million ≈ $330.63 Million |
+4.44% |
| 2009-12-31 | €270.78 Million ≈ $316.57 Million |
-7.64% |
| 2008-12-31 | €293.19 Million ≈ $342.77 Million |
+8.60% |
| 2007-12-31 | €269.97 Million ≈ $315.63 Million |
-7.22% |
| 2006-12-31 | €290.98 Million ≈ $340.18 Million |
+10.10% |
| 2005-12-31 | €264.29 Million ≈ $308.99 Million |
+29.53% |
| 2004-12-31 | €204.05 Million ≈ $238.55 Million |
+13.23% |
| 2003-12-31 | €180.21 Million ≈ $210.68 Million |
-14.33% |
| 2002-12-31 | €210.34 Million ≈ $245.91 Million |
-20.41% |
| 2001-12-31 | €264.28 Million ≈ $308.97 Million |
-99.43% |
| 2000-12-31 | €46.50 Billion ≈ $54.36 Billion |
-- |
About Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provide… Read more